Twist Bioscience Corporation Diluted Shares Outstanding (Weighted Average)
Twist Bioscience Corporation (TWST) reported Diluted Shares Outstanding (Weighted Average) of 62.40 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-03
- Twist Bioscience Corporation weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 62.40M shares, a 2.03% increase year-over-year.
- Twist Bioscience Corporation weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 61.70M shares, a 3.44% increase year-over-year.
- Twist Bioscience Corporation weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 61.08M shares, a 3.24% increase year-over-year.
- Twist Bioscience Corporation weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 60.43M shares, a 3.05% increase year-over-year.
- Twist Bioscience Corporation weighted average number of shares outstanding, diluted for fiscal 2025 was 59.81M shares, a 3.09% increase from fiscal 2024.
- Twist Bioscience Corporation weighted average number of shares outstanding, diluted for fiscal 2024 was 58.02M shares, a 1.99% increase from fiscal 2023.
- Twist Bioscience Corporation weighted average number of shares outstanding, diluted for fiscal 2023 was 56.88M shares, a 5.57% increase from fiscal 2022.
- Twist Bioscience Corporation weighted average number of shares outstanding, diluted for fiscal 2022 was 53.88M shares, a 11.68% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 62.40M shares 10-Q · filed 2026-08-03 | 62.05M shares derived: average of 2 quarters · filed 2026-08-03 | 61.73M shares 10-Q · filed 2026-08-03 | 61.40M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 61.70M shares 10-Q · filed 2026-05-04 | 61.39M shares 10-Q · filed 2026-05-04 | 61.07M shares derived: average of 3 quarters · filed 2026-05-04 | 61.09M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | 61.08M shares 10-Q/A · filed 2026-02-26 | 60.76M shares derived: average of 2 quarters · filed 2026-02-26 | 60.89M shares derived: average of 3 quarters · filed 2026-08-03 | 60.58M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-09-30 | 60.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-17 | 60.80M shares derived: average of 2 quarters · filed 2026-08-03 | 60.41M shares derived: average of 3 quarters · filed 2026-08-03 | 59.81M shares 10-K · filed 2025-11-17 |
| 2025-06-30 | 61.16M shares 10-Q · filed 2026-08-03 | 60.41M shares derived: average of 2 quarters · filed 2026-08-03 | 59.60M shares 10-Q · filed 2026-08-03 | 59.66M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | 59.65M shares 10-Q · filed 2026-05-04 | 59.40M shares 10-Q · filed 2026-05-04 | 59.15M shares derived: average of 3 quarters · filed 2026-05-04 | 58.90M shares derived: average of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | 59.16M shares 10-Q/A · filed 2026-02-26 | 58.90M shares derived: average of 2 quarters · filed 2026-02-26 | 58.65M shares derived: average of 3 quarters · filed 2026-02-26 | 58.43M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-09-30 | 58.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-17 | 58.40M shares derived: average of 2 quarters · filed 2025-11-17 | 58.19M shares derived: average of 3 quarters · filed 2025-11-17 | 58.02M shares 10-K · filed 2025-11-17 |
| 2024-06-30 | 58.15M shares 10-Q · filed 2025-08-04 | 57.96M shares derived: average of 2 quarters · filed 2025-08-04 | 57.81M shares 10-Q · filed 2025-08-04 | 57.68M shares derived: average of 4 quarters · filed 2025-11-17 |
| 2024-03-31 | 57.78M shares 10-Q · filed 2025-05-05 | 57.64M shares 10-Q · filed 2025-05-05 | 57.52M shares derived: average of 3 quarters · filed 2025-11-17 | 57.40M shares derived: average of 4 quarters · filed 2025-11-17 |
| 2023-12-31 | 57.50M shares 10-Q · filed 2025-02-03 | 57.39M shares derived: average of 2 quarters · filed 2025-11-17 | 57.27M shares derived: average of 3 quarters · filed 2025-11-17 | 57.15M shares derived: average of 4 quarters · filed 2025-11-17 |
| 2023-09-30 | 57.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-17 | 57.16M shares derived: average of 2 quarters · filed 2025-11-17 | 57.03M shares derived: average of 3 quarters · filed 2025-11-17 | 56.88M shares 10-K · filed 2025-11-17 |
| 2023-06-30 | 57.04M shares 10-Q · filed 2024-08-02 | 56.91M shares derived: average of 2 quarters · filed 2024-08-02 | 56.75M shares 10-Q · filed 2024-08-02 | 56.70M shares derived: average of 4 quarters · filed 2024-11-18 |
| 2023-03-31 | 56.78M shares 10-Q · filed 2024-05-02 | 56.61M shares 10-Q · filed 2024-05-02 | 56.58M shares derived: average of 3 quarters · filed 2024-11-18 | 56.51M shares derived: average of 4 quarters · filed 2024-11-18 |
| 2022-12-31 | 56.44M shares 10-Q · filed 2024-02-02 | 56.48M shares derived: average of 2 quarters · filed 2024-11-18 | 56.42M shares derived: average of 3 quarters · filed 2024-11-18 | 55.68M shares derived: average of 4 quarters · filed 2024-11-18 |
| 2022-09-30 | 56.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-18 | 56.41M shares derived: average of 2 quarters · filed 2024-11-18 | 55.43M shares derived: average of 3 quarters · filed 2024-11-18 | 53.88M shares 10-K · filed 2024-11-18 |
| 2022-06-30 | 56.29M shares 10-Q · filed 2023-08-07 | 54.88M shares derived: average of 2 quarters · filed 2023-08-07 | 53.01M shares 10-Q · filed 2023-08-07 | 52.26M shares derived: average of 4 quarters · filed 2023-11-21 |
| 2022-03-31 | 53.47M shares 10-Q · filed 2023-05-08 | 51.67M shares 10-Q · filed 2023-05-08 | 50.91M shares derived: average of 3 quarters · filed 2023-11-21 | 50.43M shares derived: average of 4 quarters · filed 2023-11-21 |
| 2021-12-31 | 49.91M shares 10-Q · filed 2023-02-07 | 49.64M shares derived: average of 2 quarters · filed 2023-11-21 | 49.41M shares derived: average of 3 quarters · filed 2023-11-21 | 49.24M shares derived: average of 4 quarters · filed 2023-11-21 |
| 2021-09-30 | 49.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | 49.16M shares derived: average of 2 quarters · filed 2023-11-21 | 49.01M shares derived: average of 3 quarters · filed 2023-11-21 | 48.25M shares 10-K · filed 2023-11-21 |
| 2021-06-30 | 48.96M shares 10-Q · filed 2022-08-08 | 48.84M shares derived: average of 2 quarters · filed 2022-08-08 | 47.88M shares 10-Q · filed 2022-08-08 | |
| 2021-03-31 | 48.71M shares 10-Q · filed 2022-05-06 | 47.34M shares 10-Q · filed 2022-05-06 | ||
| 2020-09-30 | 39.19M shares 10-K/A · filed 2023-06-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |